ALPS Advisors’s Immune Design Corp. IMDZ Stock Holding History

ALPS Advisors’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-85,235	Closed	-$294K	–	1009
2018 Q3	$294K	Buy	85,235 +15,400	+22%	+$57.8K	﹤0.01%	900
2018 Q2	$318K	Buy	+69,835	New	+$278K	﹤0.01%	848
2016 Q4	–	Sell	-25,720	Closed	-$195K	–	752
2016 Q3	$195K	Sell	25,720 -2,590	-9%	-$18.9K	﹤0.01%	664
2016 Q2	$231K	Buy	28,310 +5,657	+25%	+$70.5K	﹤0.01%	595
2016 Q1	$294K	Sell	22,653 -3,881	-15%	-$44.8K	﹤0.01%	579
2015 Q4	$533K	Buy	+26,534	New	+$457K	0.01%	365

Other funds holding IMDZ

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ALPS Advisors's IMDZ Position: Q4 2018 in Review

ALPS Advisors sold out of Immune Design Corp. (IMDZ) in Q4 2018, closing a stake of 85,235 shares — an estimated $294K sold.

ALPS Advisors first reported a position in IMDZ in Q4 2015 and held it in 6 quarters. The position peaked at $533K in Q4 2015. 64 funds tracked by Wall St. Rank hold IMDZ as of Q4 2018.

ALPS Advisors reported no remaining Immune Design Corp. position as of Q4 2018 after selling out during the quarter.
ALPS Advisors sold 85,235 Immune Design Corp. shares in Q4 2018, an estimated $294K.
ALPS Advisors first reported a position in Immune Design Corp. in Q4 2015 and held it in 6 quarters.
ALPS Advisors's Immune Design Corp. position peaked at $533K in Q4 2015.
64 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2018.

Based on ALPS Advisors's 13F filing for Q4 2018, filed 4 Feb 2019.